© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
December 07, 2022
Seven of the 10 top selling drugs with high price increases lack the clinical evidence to justify those increases.
November 29, 2022
A confirmatory trial of Tecentriq in urothelial carcinoma failed to meet the co-primary endpoint of overall survival.
November 10, 2022
Omnipod DASH PDMs are at increased risk of malfunction if overcharged beyond the maximum battery voltage.
September 30, 2022
Now with the brand name Relyvrio, the new therapy should be available within four to six weeks. It will have a wholesale acquisition cost of $158,000 per year.
September 27, 2022
However, researchers found that only a small percentage of plans use available real-world evidence studies and economic evaluations in their coverage policies.
September 20, 2022
Hospitalization, disability, having private high-deductible, Medicare Advantage, or no coverage were risk factors associated with medical debt.